The new COVID-19 vaccination round will start on 15 September 2025. The COVID-19 vaccination is intended for people who are at higher risk, with the aim of continuing to offer more effective protection against hospital admission or death resulting from COVID-19. The coronavirus SARS-CoV-2 is still present, so COVID-19 could surge again. The COVID-19 vaccination will be available until 5 December 2025.

Who is this vaccination for?

In autumn 2025, the COVID-19 vaccination is available to the following risk groups:

  • everyone aged 60 years and older;
  • people aged 50–59 years who are invited to get a seasonal flu vaccine every year;
  • •    adults and children with serious medical conditions (such as severe immune disorders);
  • care workers who are caring for vulnerable patients.

For some people who are not part of the target group, the COVID-19 vaccine is also available. For example, for people who have a vulnerable family member, or people who want to get a COVID-19 vaccine on the advice of their treating physician.

Invitations and appointments

Between 26 August and mid-October 2025, everyone aged 60 and older will receive an invitation letter from RIVM. People under 60 who are in one of the risk groups listed above will not receive an invitation letter. Instead, they can make an appointment from 26 August via planjeprik.nl or by calling 0800-7070.

Where can you get the vaccination?

The vaccination is given by the regional Municipal Public Health Services (GGDs) all across the Netherlands. People living in residential care facilities will receive the vaccination in their own location. 

In exceptional cases, when a serious illness, disorder or disability prevents people from going to a GGD vaccination centre on their own or with assistance, it is possible to receive the COVID-19 vaccination at home. Starting from 26 August 2025, people who are eligible for a home visit can call the GGD on 0800-7070 to arrange the appointment.

It will be the mRNA vaccine made by Pfizer/BioNTech, updated for the SARS-CoV-2 variant that is currently most prevalent.